Jan 11, 2023 / 06:30PM GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
Hi. Welcome to the Lonza presentation at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce the CEO of Lonza, Pierre-Alain Ruffieux. Before I hand over to Pierre-Alain, I would just remind everyone that we will stay in here for the Q&A of the presentation. And so if you'd like to ask a question, then please put your hand up, and there will be mics. And just wait, and we'll come to you. Pierre-Alain, great to see you.
Pierre-Alain Ruffieux - Lonza Group AG - CEO
Thank you. Good morning, everybody. A warm welcome to all of you. It's really good to see you after 2 year, back face to face. I think we have already -- we have almost 40 minutes together. In the first part, I'm going to share a brief update on our business. Then I'm looking forward to hear your questions.
The agenda today is the following: I will start with the short company background, highlighting some aspects of
Lonza Group AG at JPMorgan Healthcare Conference Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers